Fibromyalgia as an interdisciplinary problem — the possibilities and prospects of diagnosis and treatment

The article discusses fibromyalgia (FM) as a topical interdisciplinary problem. From the point of view of modern medicine, FM is considered a chronic disease characterized by widespread persistent musculoskeletal pain of a non-inflammatory nature, which is accompanied by fatigue, sleep disturbances and cognitive impairments. The authors focused on a review of the literature on the etiology of FM, which is a multifactorial disease — in particular, genetic predisposition and the state of the intestinal microbiota are of great importance in its development. The criteria for clinical diagnosis of FM should be widely used — the diagnosis can be made in primary health care settings based on the assessment of compliance with the criteria of The American College of Rheumatology (ACR, 2016) and subject to normal results of physical examination and laboratory tests, excluding other diseases. The authors draw attention to the importance of an integrated approach (pharmacotherapy, physical rehabilitation, psychotherapy) in the treatment of FM — the point of view of doctors and psychologists is presented. 

1. Wolfe F., Smythe H. A., Yunus M. B. et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee // Arthritis Rheum. 1990; 33 (2): 160–172.

2. Wolfe F., Clauw D. J., Fitzcharles M. A. et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity // Arthritis Care Res (Hoboken). 2010; 62 (5): 600–610.

3. Wolfe F., Clauw D. J., Fitzcharles M. A. et al. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia // J Rheumatol. 2011; 38 (6): 1113–1122.

4. Wolfe F., Clauw D. J., Fitzcharles M. A., et al. 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria // Semin Arthritis Rheum. 2016; 46 (3): 319–329.

5. Kolokolov O.V., Kolokolova A.M, Sitkali I.V. Fibromialgiya: novoye o mezhdunarodnykh kriteriyakh diagnostiki i taktiki vedeniya patsiyentov [Fibromyalgia: new about international diagnostic criteria and patient management tactics] Terapiya. 2017; №5 (15): pp 94–104.

6. Kolokolov O.V., Sitkali I.V., Shakhpazov S.Zh., Kolokolova A.M Sindrom khronicheskoy rasprostranennoy boli — novaya mezhdistsiplinarnaya problema ili kompetentsiya vracha obshchey praktiki? [Chronic pain syndrome — a new interdisciplinary problem or the competence of a general practitioner?] Farmateka. 2018; №5: pp 71–80.

7. Häuser W., Ablin J., Fitzcharles M. A. et al. Fibromyalgia // Nat Rev Dis Primers. 2015; 1: 15022.

8. Jakobsson U. The epidemiology of chronic pain in a general population: results of a survey in southern Sweden // Scand J Rheumatol. 2010; 39: 421–429.

9. Jones G. T., Atzeni F., Beasley M. et al. The prevalence of fibromyalgia in the general population: a comparison of the American College of Rheumatology 1990, 2010, and modified 2010 classification criteria // Arthritis Rheumatol. 2015; 67: 568–575.

10. Mansfield K. E., Sim J., Jordan J. L., Jordan K. P. A systematic review and meta-analysis of the prevalence of chronic widespread pain in the general population // Pain. 2016; 157 (1): 55–64.

11. Marques A. P., Santo A. S., Berssaneti A. A. et al. Prevalence of fibromyalgia: literature review update // Rev Bras Reumatol Engl Ed. 2017; 57 (4): 356–363.

12. Waylonis G. W., Heck W. Fibromyalgia syndrome. New associations // Am J Phys Med Rehabil. 1992; 71: 343–348.

13. Galvez-Sánchez C. M., Reyes Del Paso G. A. Diagnostic Criteria for Fibromyalgia: Critical Review and Future Perspectives // J Clin Med. 2020; 9 (4): 1219.

14. Buskila D., Sarzi-Puttini P. Biology and therapy of fibromyalgia. Genetic aspects of fibromyalgia syndrome // Arthritis Research & Therapy. 2006; 8 (5): 218.

15. Park D.-J., Lee S.-S. New insights into the genetics of fibromyalgia // The Korean journal of internal medicine. 2017; 32 (6): 984–995.

16. D’Agnelli S., Arendt-Nielsen L., Gerra M. C. et al. Fibromyalgia: Genetics and epigenetics insights may provide the basis for the development of diagnostic biomarkers // Molecular Pain. 2019; 15: 1–12.

17. Feng J., Zhang Z., Wu X. et al. Discovery of potential new gene variants and inflammatory cytokine associations with fibromyalgia syndrome by whole exome sequencing // PLoS One. 2013; 8: e65033.

18. Docampo E., Escaramis G., Gratacos M. et al. Genome-wide analysis of single nucleotide polymorphisms and copy number variants in fibromyalgia suggest a role for the central nervous system // Pain. 2014; 155 (6): 1102–1109.

19. Kim S.-K., Kim S.-H., Nah S.-S. et al. Association of guanosine triphosphate cyclohydrolase 1 gene polymorphisms with fibromyalgia syndrome in a Korean population // J Rheumatol. 2013; 40 (3): 316–322.

20. Murphy Jr. G. M., Sarginson J. E., Ryan H. S. et al. BDNF and CREB1 genetic variants interact to affect antidepressant treatment outcomes in geriatric depression // Pharmacogenet Genomics. 2013; 23 (6): 301–313.

21. Sarchielli P., Mancini M. L., Floridi A. et al. Increased levels of neurotrophins are not specifc for chronic migraine: evidence from primary fbromyalgia syndrome // J Pain. 2007; 8 (9): 737–745.